Elon Musk-Owned Neuralink's Brain Implant Could Fetch Over $220M Revenue In ALS Patients By 2030, Says Ark Analyst

Elon Musk’s Neuralink will likely collect sizeable revenue from its N1 brain implant in out years, according to an analyst at Ark Investment Management.

What Happened: If the N1 module and R1 surgical robot succeed in getting FDA approval for ALS, a neurodegenerative disorder that results in progressive degeneration of nerve cells in the spinal cord and brain, and cervical spinal cord injuries, there will likely be modest adoption by 2025, said Ark analyst Pierce Jamieson.

Neuralink’s N1 implant is cosmetically invisible and is intended to record and transmit brain signals wirelessly to an app that decodes movement intention. The R1 Robot will be used to surgically place the N1 Implant's ultra-fine and flexible threads in a region of the brain that controls movement intention.

Annual revenue for N1 devices alone could surpass $220 million by 2030, Jamieson said, citing the firm’s preliminary research.

See Also: Best Healthcare Stocks To Buy Now

Why It’s Important: Neuralink is developing brain-machine interfaces BMIs, that link the human brain with computers and build on the works of other technologies like deep brain stimulation, electrocorticography, and machine learning, Jamieson said. “Neuralink has significant potential to transform medicine and accelerate the link between humans and artificial intelligence,” he said.

The technology also could bypass spinal cord injuries and transmit brain signals directly to devices that help amputees regain mobility and control, the analyst said. Longer term, BMIs could treat ALS, Parkinson’s disease, epilepsy, sensory disorders, stroke-related brain injury, and many other conditions, he added.

In late May, Neuralink received FDA approval for commencing its first-in-human clinical trial.

The iShares U.S. Medical Devices ETF IHI ended Tuesday’s session up 0.72% at $46.17, according to Benzinga Pro data.

Read Next: Elon Musk Says Neuralink Is The Only Way To Survive And Compete With AI